title: Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine.
authors.affiliation: Department of Hematology, School of Medicine, Democritus University of Thrace, Alexandroupolis, Greece. ktsatala@med.duth.gr
authors.forename: C
authors.initials: C
authors.lastname: Tsatalas
authors.forename: D
authors.initials: D
authors.lastname: Margaritis
authors.forename: V
authors.initials: V
authors.lastname: Kaloutsi
authors.forename: G
authors.initials: G
authors.lastname: Martinis
authors.forename: I
authors.initials: I
authors.lastname: Kotsianidis
authors.forename: G
authors.initials: G
authors.lastname: Bourikas
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D018572:Disease-Free Survival; D004334:Drug Administration Schedule; D006801:Humans; D007119:Immunoblastic Lymphadenopathy / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy*; D016399:Lymphoma, T-Cell / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D014740:Vidarabine / Q000008:administration & dosage* / Q000031:analogs & derivatives*
chemical_list: D014740:Vidarabine; C024352:fludarabine